The report presents a comprehensive research of the global prostate cancer testing market by product that includes biomarkers, biopsy, and imaging. The report also determines the geographic breakdown of the market in terms of detailed analysis and impact, which includes key geographies such as APAC, the Americas, and EMEA.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers
Market driver: increasing incidence of prostate cancer
The incidence of prostate cancer is increasing across the globe. It is the second most common cancer diagnosed in men. It is estimated that around one million new cases of prostate cancer are diagnosed around the world every year. It was projected that around 220,000 deaths occur every year due to prostate cancer. According to a research, in 2014, approximately 172,258 men in the US were diagnosed with prostate cancer, and 28,343 men died from it.
According to a senior analyst at Technavio for orthopedics and medical devices research, “The incidence rate of prostate cancer has increased tremendously over the last few decades because of the increasing older population and growing urbanization and associated lifestyle changes. In 2017, around 650 million people were aged 65 and above globally. Prostate cancer is determined to be the most common malignancy among older men.”
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Market trend: increasing focus on biomarker research
Biomarkers in prostate cancer are expanding rapidly, and the recent developments in high throughput technology platforms in proteomics, genomics, and immunology fields have accelerated the development of biomarkers. Due to the inherent drawbacks and limitations of the biomarker PSA, significant efforts are being directed towards the development of alternative prostate cancer biomarkers, particularly those which can predict disease aggressiveness and drive better treatment decisions.
Market challenge: limitations and complications associated with prostate cancer diagnostic tests
Prostate cancer diagnostic tests are associated with several complications and drawbacks. PSA testing for prostate cancer is a controversial topic of debate among clinicians, and there are significant limitations that are deterring its widespread adoption as a screening technique for prostate cancer detection. PSA tests can provide a false positive or negative reading due to many reasons.
Is your business on track for a successful future? Learn how Technavio can help
Technavio helps businesses anticipate changes in their marketplace, make proactive adjustments, and develop effective strategies to optimize their market positions.
Technavio’s best deals of the month!
Technavio supports Health for All campaign on this World Health Day with 20% savings on all reports in the Health and Wellness category for the entire month.
Celebrate International Astronomy Day by indulging in a whopping 30% savings on all reports in the Space category. Offer valid from 16th April for a limited period.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.